| TRADING CENTER |
| QIAGEN Added to NASDAQ-100 Index - GlobeNewswire | |
| QIAGEN Announces Closing of the Acquisition of SABiosciences - Market Wire | |
| NASDAQ Announces the Annual Re-Ranking of the NASDAQ-100 Index - GlobeNewswire |
| Last trade | Change/%change | P/E ratio | ||
|---|---|---|---|---|
| AMGN | Amgen Inc | 57.42 | 0.00 / 0.00% | 10.98 |
| GILD | Gilead Sciences Inc | 43.00 | 0.00 / 0.00% | 16.60 |
| CELG | Celgene Corporation | 56.38 | 0.00 / 0.00% | 67.93 |
| 2008 Revenue: | $893.0 M | Headquarters: KJ Venlo, |
| Employees: | 3,041 | CEO: Peer M. Schatz |
| Net Income: | $89.0 M | Industry: Biotechnology |
| Market Cap: | $5.2 B | Website: www.qiagen.com |
| Symbol | Price | Change/%Change | Prev. close | High | Low | Last Update | More Info |
|---|---|---|---|---|---|---|---|
| QGEN | 22.57 | 0.00 / 0.00% | 22.57 | 0.00 | 0.00 | Profile Chart News |